跳至主要内容
临床试验/NCT05672407
NCT05672407撤回4 期

The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery

University of Miami0 个研究点开始时间: 2023年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
主要终点
Postoperative patient ecchymosis

研究概览

简要总结

This study investigates the effect of tranexamic acid, a medication that helps reduce bleeding, in patients undergoing surgeries around their eyes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults age 18 and above undergoing periorbital oculoplastic surgery including but not limited to upper and lower blepharoplasty, four lid procedures, or dacryocystorhinostomy (DCR).

排除标准

  • - Adults unable to consent
  • Individuals less than 18 years of age
  • Prisoners
  • Pregnant women.
  • Known contradictions or sensitivities to study medication (tranexamic acid)
  • Patients with known prior thromboembolic events
  • Previous eyelid surgery or same-side DCR (RE-DCR)
  • Has any type of coagulopathy

研究组 & 干预措施

Tranexamic Acid Group

Experimental

Participants undergoing standard of care periorbital procedures will be randomized to receive tranexamic acid with lidocaine/epinephrine on one of their eyelids at the beginning of the scheduled operation before incision.

干预措施: Tranexamic acid (Drug)

Placebo Group

Placebo Comparator

Participants undergoing standard of care periorbital procedures will be randomized to receive balanced salt solution with lidocaine/epinephrine on one of their eyelids at the beginning of the scheduled operation before incision.

干预措施: Placebo (Drug)

结局指标

主要结局

Postoperative patient ecchymosis

时间窗: Up to 3 months

Ecchymosis will be graded 0-3 based on location and degree based on a previously reported validated scale (higher scores with more ecchymosis)

次要结局

  • Patient-perceived outcomes(Up to 3 months)
  • Postoperative patient chemosis(Up to 3 months)
  • Eyelid edema(Up to 3 months)
  • Intraoperative patient bleeding(Postoperative day 0 (day of surgery))
  • Physician Perception of Intraoperative Bleeding(Postoperative day 0 (day of surgery))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wendy Lee

Professor of Clinical Ophthalmology

University of Miami

相似试验